-
Boni C, Radighieri E, Bertolini V, Formisano D, Zanelli F.
Cisplatin, Etoposide and Ifosfamide (PEI) in the treatment of small cell lung cancer: monoinstitutional experience of 59 consecutive cases.
[Abstract of the 2. European Lung Cancer Conference, 28 April-1 May 2010 in Geneva, Switzerland.]
J Thorac Oncol. 2010 May;5(5 Suppl 1):S109. Abstract 278P.
Nº Standard (ISBN/DOI): 10.1097/01.JTO.0000372622.81561.0e
Material Type: Journal Article
Publication Types: Congresses | Overall
Lingua: Inglese
Ricevuto in biblioteca: 25/10/2010
-
Boni C, André T, Banzi MC, Hickish T, Tabernero J, Clingan P, Chibaudel B, de Gramont A.
Similarities and Differences Between the Adjuvant Oxaliplatin-Based Trials MOSAIC and NSABP C-07.
Curr Colorectal Cancer Rep. 2009 Jul;5(3):166-70.
Nº Standard (ISBN/DOI): 10.1007/s11888-009-0024-7
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 03/08/2009
-
Bisagni G, Rossi G, Cavazza A, Sartori G, Gardini G, Boni C.
Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma.
J Thorac Oncol. 2009 Jun;4(6):773-5.
Nº Standard (ISBN/DOI): 10.1097/JTO.0b013e3181a52e25
Material Type: Journal Article
Publication Types: Case Reports
Impact Factor: 4,547
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Guarneri V, Frassoldati A, Ficarra G, Puglisi F, Andreetta C, Michelotti A, Cresti N, Boni C, Bisagni G, Berardi R, Battelli N, Santoro A, Banna G, Bottini A, Di Blasio B, Maiorana A, Piacentini F, Giovannelli S, Jovic G, Conte P.
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
Breast Cancer Res Treat. 2008 Jul;110(1):127-34.
Material Type: Journal Article
Impact Factor: 5,684
Lingua: Inglese
Ricevuto in biblioteca: 23/04/2009
-
Musolino A, Naldi N, Bortesi B, Pezzuolo D, Capelletti M, Missale G, Laccabue D, Zerbini A, Camisa R, Bisagni G, Neri TM, Ardizzoni A.
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
J Clin Oncol. 2008 Apr 10;26(11):1789-96.
Material Type: Journal Article
Impact Factor: 17,157
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research. Collaborators: Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
J Natl Cancer Inst. 2008 Mar 19;100(6):388-98.
Nº Standard (ISBN/DOI): 10.1093/jnci/djn054
Material Type: Journal Article
Impact Factor: 14,933
Lingua: Inglese
Ricevuto in biblioteca: 27/04/2009
-
Chiesa MD, Passalacqua R, Michiara M, Franciosi V, Di Costanzo F, Bisagni G, Camisa R, Buti S, Tomasello G, Cocconi G; Italian Oncology Group for Clinical Research.
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.
Acta Biomed. 2007 Dec;78(3):204-9.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Tiseo M, Boni C, Baldini E, Boni L, Recchia F, Barone C, Manzione L, Grossi F, Matano E, Zanelli F, Prochilo T, Ardizzoni A.
Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: preliminary results of a multicenter randomized factorial study.
[Abstract of the 9. National Congress of Medical Oncology. 12-15 October, 2007; Palermo, Italy].
Ann Oncol. 2007 Oct;18(Suppl 11):xi36. Abstract B53.
Material Type: Journal Article
Publication Types: Congresses
Impact Factor: 4,875
Lingua: Inglese
Ricevuto in biblioteca: 26/10/2010
-
Boni C, Baldini E, Boni L, Tiseo M, Recchia F, Barone C, Manzione L, Zanelli F, Prochilo T, Ardizzoni A.
Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: preliminary results of a multicenter randomized factorial study.
[Abstract of the 12. World Conference on Lung Cancer. 2-6 September 2007; Seoul, Korea]
J Thorac Oncol. 2007 Aug;2(8 Suppl 4):S318. Abstract A3-06
Nº Standard (ISBN/DOI): 10.1097/01.JTO.0000283109.78009.62
Material Type: Journal Article
Publication Types: Congresses | Overall
Impact Factor: 1,429
Lingua: Inglese
Ricevuto in biblioteca: 26/10/2010
-
Gori S, Rimondini S, De Angelis V, Colozza M, Bisagni G, Moretti G, Sidoni A, Basurto C, Aristei C, Anastasi P, Crinò L.
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
Oncologist. 2007 Jul;12(7):766-73.
Material Type: Journal Article
Impact Factor: 4,876
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Boni C, Zanelli F, Ambroggi M, Bologna A.
Non-small-cell lung cancer: which platinum for gemcitabine?
Ann Oncol. 2006 May;17 Suppl 5:v79-81.
Nº Standard (ISBN/DOI): 10.1093/annonc/mdj956
Material Type: Journal Article
Publication Types: Review | Evaluation Studies
Impact Factor: 5,179
Lingua: Inglese
Ricevuto in biblioteca: 26/10/2010
-
Bozzetti C, Musolino A, Camisa R, Bisagni G, Flora M, Bassano C, Martella E, Lagrasta C, Nizzoli R, Personeni N, Leonardi F, Cocconi G, Ardizzoni A.
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity.
Am J Clin Oncol. 2006 Apr;29(2):171-7.
Nº Standard (ISBN/DOI): 10.1097/01.coc.0000204405.96572.f9
Material Type: Journal Article
Impact Factor: 1,224
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
De Maio E, Perrone F, Bisagni G, Boni C.
The new drugs advent: clinical or economic outcomes?.
Ann Oncol. 2006 Mar;17(Suppl 2):ii88-90.
Material Type: Journal Article
Impact Factor: 5,179
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Cocconi G, Di Blasio B, Boni C, Bisagni G, Rondini E, Bella MA, Leonardi F, Savoldi L, Vallisneri C, Camisa R, Bruzzi P; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy.
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Ann Oncol. 2005 Sep;16(9):1469-76.
Material Type: Journal Article
Impact Factor: 4,319
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Colozza M, Sidoni A, Mosconi AM, Cavaliere A, Bisagni G, Gori S, De Angelis V, Frassoldati A, Cherubini R, Bian AR, Rodino C, Mazzocchi B, Mihailova Z, Bucciarelli E, Tonato M; Italian Oncology Group for Clincal Research.
HER2 overexpression as a predictive marker in a randomized trial comparing adjuvant cyclophosphamide/methotrexate/5-fluorouracil with epirubicin in patients with stage I/II breast cancer: long-term results.
Clin Breast Cancer. 2005 Aug;6(3):253-9.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Zanelli F, Bisagni G, Linarello P, Ferrari G, Paci M, Sgarbi G, Carbonelli C, Falco F, Formisano D, Flora M, Gardini G, Boni C.
Her-2 amplification (Her-2 +) and chromosome 17 polysomy as prognostic factors in patients with radically resected non small cell lung cancer (NSCLC).
[Abstract of the 6. National Congress of Medical Oncology, 21-24 September, 2004: Bologna, Italy].
Ann Oncol. 2004 Sep;15(Suppl 2):ii40. Abstract C16.
Nº Standard (ISBN/DOI): 10.1093/annonc/mdh703
Material Type: Journal Article
Publication Types: Congresses | Overall
Impact Factor: 4,335
Lingua: Inglese
Ricevuto in biblioteca: 25/10/2010
-
Paci M, De Franco S, Sozzi G, Ferrari G, Bellesia E, Accardo P, Nicoli D, Flora M, Cavazza A, Versari A, Giovanardi F, Zanelli F, Falco F, Toffanetti R, Polico R, Pedroni M, Annessi V, Zucchi L, Boni C, Gardini G, Salvo D, Armaroli L, Sgarbi G.
Il cancro del polmone. Nuove strategie per la diagnosi precoce.
Lo Spallanzani 2004;18(2):91-93
Material Type: Journal Article
Lingua: Italiano
Ricevuto in biblioteca: 01/12/2008
-
Ludovini V, Sidoni A, Pistola L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodinò C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M.
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.
Breast Cancer Res Treat. 2003 Sep;81(2):159-68
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Cocconi G, Carlini P, Gamboni A, Gasperoni S, Rodinò C, Zironi S, Bisagni G, Porrozzi S, Cognetti F, Di Costanzo F, Canaletti R, Ruggeri EM, Camisa R, Pucci F; Italian Oncology Group for Clinical Research.
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
Ann Oncol. 2003 Aug;14(8):1258-63.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Boni C, Zanelli F.
Ifosfamide in non-small cell lung cancer.
Oncology. 2003;65 Suppl 2:50-4.
Nº Standard (ISBN/DOI): 10.1159/000073359
Material Type: Journal Article
Publication Types: Review | Research Support, Non-U.S. Gov't
Impact Factor: 2,381
Lingua: Inglese
Ricevuto in biblioteca: 26/10/2010
-
Colozza M, Bisagni G, Mosconi AM, Gori S, Boni C, Sabbatini R, Frassoldati A, Passalacqua R, Bian AR, Rodinò C, Rondini E, Algeri R, Di Sarra S, De Angelis V, Cocconi G, Tonato M.
Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study.
Eur J Cancer. 2002 Nov;38(17):2279-88.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Cocconi G, Di Blasio B, Boni C, Bisagni G, Ceci G, Rondini E, Bella M, Leonardi F, Savoldi L, Camisa R, Bruzzi P.
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cancer. 2002 Jul 15;95(2):228-35.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
-
Bonini A, Bisagni G, Boni C, Gugliotta L.
Reduced-intensity allogeneic bone marrow transplantation in renal cell carcinoma- A case report.
[Abstract of the 7th Congress of the European Haematology Association, EHA. 6-9 Juni 2002; Florence, Italy].
Hematol J. 2002;3(Suppl 1). Abstract 1266.
Material Type: Journal Article
Publication Types: Congresses | Overall
Lingua: Inglese
Ricevuto in biblioteca: 12/08/2010
-
Ferrari G, Paci M, De Franco S, Annessi V, Versari A, Toffanetti R, Carbonelli C, Bisagni G, Cavazza A, Giovanardi F, D'Abbiero N, Vignoli R, Boni F, Massobrio M, Boni C, Zucchi L, Sgarbi G.
Il cancro al polmone. Dalla stadiazione morfologica a quella biologica: proposta di un protocollo multidisciplinare.
Lo Spallanzani. 2002;16:103-106.
Material Type: Journal Article
Lingua: Italiano
Ricevuto in biblioteca: 01/12/2008
-
Bisi A, Capalbo M, Calabrese L, Cordella C, Dardani M, De Pietri S, Donadio A, Ferretti A, Fornaciari G, Gherardi C, Guidetti D, Manari D, Magnani E, Magnani P, Navazio A, Rustichelli R, Passatelli R, Salvarani C, Sassi M, Scurti M, Sgarbi G, Stigliani F, Viani N. a cura dell'Unità per l'Efficacia Clinica. La profilassi del danno gastrointestinale da farmaci. Appropriatezza e Gestione del Rischio. Reggio Emilia : [s.n.], 2001. 17 p.
Material Type: Gray Literature
Publication Types: Guideline
Lingua: Italiano
Ricevuto in biblioteca: 02/07/2009
-
Boni C, Bisagni G, Savoldi L, Moretti G, Rondini E, Sassi M, Zadro A, De Pas T, Franciosi V, Pazzola A, Vignoli R, Banzi MC, Pajetta V.
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC).
Int J Cancer. 2000 Sep 1;87(5):724-7.
Material Type: Journal Article
Lingua: Inglese
Ricevuto in biblioteca: 28/09/2009
